Evidence map›Paper›PMID 38617272›Full record

ArticlebioRxiv : the preprint server for biology2024

Single-cell image-based genetic screens systematically identify regulators of Ebola virus subcellular infection dynamics.

Rebecca J Carlson, J J Patten, George Stefanakis, Brian Y Soong, Adityanarayanan Radhakrishnan, Avtar Singh, Naveen Thakur, Gaya K Amarasinghe, Nir Hacohen, Christopher F Basler and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Rebecca J CarlsonMassachusetts Institute of Technology, Department of Health Sciences and Technology, Cambridge, MA, USA.ORCID 0000-0002-5423-9717
J J PattenDepartment of Virology, Immunology, and Microbiology, Boston University School of Medicine, Boston, MA, USA.
George StefanakisLaboratory for Information & Decision Systems, Massachusetts Institute of Technology, Cambridge, MA, USA.
Brian Y SoongBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-4647-7704
Adityanarayanan RadhakrishnanBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-0878-815X
Avtar SinghBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Naveen ThakurDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0009-0008-9537-8423
Gaya K AmarasingheDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-0418-9707
Nir HacohenBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-2349-2656
Christopher F BaslerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-4195-425X
Daisy LeungDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-7189-9557
Caroline UhlerBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-7008-0216
Robert A DaveyDepartment of Virology, Immunology, and Microbiology, Boston University School of Medicine, Boston, MA, USA.ORCID 0000-0001-9168-2892
Paul C BlaineyBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-4889-8783
Broad Institute · USBoston University · USIcahn School of Medicine at Mount Sinai · USWashington University in St. Louis · USDecision Systems (United States) · US

Funding

Virology BSL4 CoreP01AI120943 · NIAID · WASHINGTON UNIVERSITY · PI Gaya K. Amarasinghe · 2016 to 2026
$30.2M
Center for Cell CircuitsRM1HG006193 · NHGRI · BROAD INSTITUTE, INC. · PI BLAINEY, PAUL CLARK, HACOHEN, NIR · 2016 to 2020
$14.9M
High-content optical pooled genome-wide screens of SARS-CoV-2 infectionR01HG009283 · NHGRI · BROAD INSTITUTE, INC. · PI BLAINEY, PAUL CLARK · 2017 to 2020
$4.8M
Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus InfectionR01AI148663 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BASLER, CHRISTOPHER F · 2020 to 2024
$3.0M
NHGRI NIH HHS R01 HG009283NHGRI NIH HHS RM1 HG006193NIAID NIH HHS P01 AI120943NIAID NIH HHS R01 AI148663
6 · The paper itself

Abstract

Ebola virus (EBOV) is a high-consequence filovirus that gives rise to frequent epidemics with high case fatality rates and few therapeutic options. Here, we applied image-based screening of a genome-wide CRISPR library to systematically identify host cell regulators of Ebola virus infection in 39,085,093 million single cells. Measuring viral RNA and protein levels together with their localization in cells identified over 998 related host factors and provided detailed information about the role of each gene across the virus replication cycle. We trained a deep learning model on single-cell images to associate each host factor with predicted replication steps, and confirmed the predicted relationship for select host factors. Among the findings, we showed that the mitochondrial complex III subunit UQCRB is a post-entry regulator of Ebola virus RNA replication, and demonstrated that UQCRB inhibition with a small molecule reduced overall Ebola virus infection with an IC50 of 5 μM. Using a random forest model, we also identified perturbations that reduced infection by disrupting the equilibrium between viral RNA and protein. One such protein, STRAP, is a spliceosome-associated factor that was found to be closely associated with VP35, a viral protein required for RNA processing. Loss of STRAP expression resulted in a reduction in full-length viral genome production and subsequent production of non-infectious virus particles. Overall, the data produced in this genome-wide high-content single-cell screen and secondary screens in additional cell lines and related filoviruses (MARV and SUDV) revealed new insights about the role of host factors in virus replication and potential new targets for therapeutic intervention.

Identifiers

PMID38617272
PMCPMC11014611
OpenAlexW4394573880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.